CI CignacompanySEC Filings & Insider Trading Activity 2026
Latest Cigna (CI) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 26, 2026, a 10-Q quarterly report filed on October 30, 2025, an 8-K current report filed on April 30, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Cigna (CI) (SEC CIK 1739940), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Management Discussion & Analysis
- • Revenue $274.9B, up $27.8B (+11%) YoY; pharmacy revenues dominant driver, up $31.3B (+17%) from Evernorth customer growth
- • Evernorth (best segment): adjusted revenues $235B, pre-tax margin 3.1% vs 3.5%; Cigna Healthcare (worst): revenues down 11% to $47.2B, MCR 84.4% vs 83.2%
Risk Factors
- • FTC administrative complaint against Express Scripts (Sept 2024) for anticompetitive insulin rebate practices; settled Feb 2026 with no penalty but required business practice changes
- • Total indebtedness ~$31.5B as of Dec 31, 2025, representing significant leverage constraining capital allocation flexibility
Business Overview
- • Global health company operating two core segments: Evernorth Health Services (PBM/specialty pharmacy) and Cigna Healthcare (medical benefits), serving 185M+ customer relationships across 30+ markets
- • Completed sale of Medicare Advantage, Medicare Part D, and CareAllies businesses to HCSC on March 19, 2025 — major portfolio exit, marking deliberate retreat from government-sponsored individual Medicare market
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Management Discussion & Analysis
- • No quarterly revenue or YoY change data provided in disclosed text
- • No profitability or margin figures included in provided section
Risk Factors
- • Debt securities portfolio carrying value decreased from $9.4B to $8.4B due to HCSC transaction, unrealized depreciation from rising interest rates
- • Commercial mortgage loan portfolio $1.3B with <25% exposure to office properties amid weak sector fundamentals beginning to stabilize
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 7.01: Regulation FD Disclosure
- • 2026 EPS guidance reaffirmed at ≥$30.25 adjusted income from operations per share
- • Evernorth segment 2026 pre-tax adjusted income reaffirmed at ≥$6.9B
Item 5.02: Departure/Appointment of Directors or Principal Officers
- • Brian Evanko, 49, named CEO effective July 1, 2026; succeeds David Cordani, who becomes Executive Chair
- • Evanko total target compensation: $1.3M base salary + $2.6M EIP + $15.1M LTI annually
Annual Reports Archive10-K
AI-powered analysis of Cigna (CI) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of Cigna (CI) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Cigna (CI) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $180.5B | $195.3B | $247.1B | $274.9B |
| Operating Income | $8.4B | $8.5B | $9.4B | $9.2B |
| Net Income | $6.7B | $5.2B | $3.4B | $6.0B |
| Op. Margin | 4.7% | 4.4% | 3.8% | 3.3% |
| Net Margin | 3.7% | 2.6% | 1.4% | 2.2% |
| Balance Sheet | ||||
| Total Assets | $143.9B | $152.8B | $155.9B | $157.9B |
| Equity | $44.9B | $46.2B | $41.0B | $41.7B |
| ROE | 14.9% | 11.2% | 8.4% | 14.3% |
Source: XBRL financial data from Cigna (CI) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 30, 2026 | — | — | — |
8-K | Apr 27, 2026 | — | — | — |
8-K | Mar 3, 2026 | — | Analysis | — |
8-K | Feb 27, 2026 | — | Analysis | — |
10-K | Feb 26, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 5, 2026 | — | — | |
10-Q | Oct 30, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Jul 31, 2025 | Jun 30, 2025 | Analysis | |
10-Q | May 2, 2025 | Mar 31, 2025 | Analysis | |
10-K | Feb 27, 2025 | Dec 31, 2024 | Analysis | |
10-Q | Oct 31, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 1, 2024 | Jun 30, 2024 | — | |
10-Q | May 2, 2024 | Mar 31, 2024 | — | |
10-K | Feb 29, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 2, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 3, 2023 | Jun 30, 2023 | — | |
10-Q | May 5, 2023 | Mar 31, 2023 | — | |
10-K | Feb 23, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 3, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 4, 2022 | Jun 30, 2022 | — | |
10-Q | May 6, 2022 | Mar 31, 2022 | — | |
10-K | Feb 24, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 4, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 5, 2021 | Jun 30, 2021 | — | |
10-Q | May 7, 2021 | Mar 31, 2021 | — |
Frequently Asked Questions
What are the latest CI SEC filings in 2026?
Cigna (CI) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on October 30, 2025, an 8-K current report on April 30, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did CI file its most recent 10-K annual report?
Cigna (CI) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view CI 10-Q quarterly reports?
Cigna (CI)'s most recent 10-Q quarterly report was filed on October 30, 2025. SignalX displays every CI 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has CI filed recently?
Cigna (CI)'s most recent 8-K was filed on April 30, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find CI insider trading activity (Form 4)?
SignalX aggregates every CI Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does CI file with the SEC?
Cigna (CI) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new CI filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Cigna (CI).
What is CI's SEC CIK number?
Cigna (CI)'s SEC CIK (Central Index Key) number is 1739940. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1739940 to look up all CI filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find CI return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Cigna (CI) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Cigna SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 34+ filings.